Quintet Private Bank (Europe)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-174
Closed -$3.75K 252
2023
Q4
$3.75K Sell
174
-544
-76% -$10K ﹤0.01% 185
2023
Q3
$13.3K Buy
718
+457
+175% +$10.7K ﹤0.01% 195
2023
Q2
$6.68K Sell
261
-4
-2% -$101 ﹤0.01% 230
2023
Q1
$6.87K Buy
+265
New +$7.09K ﹤0.01% 255
2022
Q2
$6.68K Buy
+261
New +$11.1K ﹤0.01% 230

Other funds holding TDOC

Quintet Private Bank (Europe)'s TDOC Position: Q1 2024 in Review

Quintet Private Bank (Europe) sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 174 shares — an estimated $3.75K sold.

Quintet Private Bank (Europe) first reported a position in TDOC in Q2 2022 and held it in 5 quarters. The position peaked at $13.3K in Q3 2023. 427 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Quintet Private Bank (Europe) reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Quintet Private Bank (Europe) sold 174 Teladoc Health shares in Q1 2024, an estimated $3.75K.
  • Quintet Private Bank (Europe) first reported a position in Teladoc Health in Q2 2022 and held it in 5 quarters.
  • Quintet Private Bank (Europe)'s Teladoc Health position peaked at $13.3K in Q3 2023.
  • 427 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Quintet Private Bank (Europe)'s 13F filing for Q1 2024, filed 15 May 2024.